NSE - Delayed Quote INR

Sun Pharma Advanced Research Company Limited (SPARC.NS)

Compare
209.84 +4.71 (+2.30%)
At close: 3:30 PM GMT+5:30

Research Analysis

Revenue vs. Earnings

Revenue 168.1M
Earnings -959M
Q4'23
Q1'24
Q2'24
-1B
-800M
-600M
-400M
-200M
0
?

Analyst Price Targets

1,194.00
1,282.00 Average
209.84 Current
1,370.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2025)Next Year (2026)
No. of Analysts 1--1--
Avg. Estimate 547B--547B--
Low Estimate 547B--547B--
High Estimate 547B--547B--
Year Ago Sales 755.5M--755.5M547B
Sales Growth (year/est) 72,302.40%--72,302.40%--

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 00440
30 Days Ago 00440
60 Days Ago 00440
90 Days Ago 00440

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD SPARC.NSIndustrySectorS&P 500
Current Qtr. ------5.40%
Next Qtr. ------11.80%
Current Year ------2.20%
Next Year ------12.50%
Next 5 Years (per annum) ------11.03%
Past 5 Years (per annum) --------

Related Tickers